FindTrial
Sign In

To investigate the effect of brain protection and mechanism of dexmedetomidine on treatment of cerebral infarction

To investigate the effect of brain protection and mechanism of dexmedetomidine on treatment of cerebral infarction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040110
Enrollment
Unknown
Registered
2020-11-21
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral infarction

Interventions

dexmedetomidine:dexmedetomidine

Sponsors

Department of Anesthesiology, Tongji Hospital, Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Stroke patients younger than 80 years old, ASA grade 2-3, volunteers and signed informed consent.

Exclusion criteria

Exclusion criteria: Patients with severe traumatic brain injury, previous cerebral infarction, epilepsy and other neurological diseases; patients with severe heart, lung, liver and kidney dysfunction; patients with psychological or mental diseases; patients with severe blood system diseases or abnormal coagulation function; patients with allergy to narcotic drugs and contrast agents.

Design outcomes

Primary

MeasureTime frame
Cerebral infarction area;—

Secondary

MeasureTime frame
Delayed Neurocognitive Recovery,DNR;Mini-Mental State Examination,MMSE;Activities of Daily Living,ADL;Glasgow Coma Scale,GCS;National Institutes of Health Stroke Scale,NIHSS;—

Countries

china

Contacts

Public ContactJunjun Yang

Tongji Hospital Affiliated to Tongji University

sifashixi@126.com+86 13761622009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026